LILLY REORGANIZATION INTO DISEASE-BASED BUSINESS UNITS ADVANCES FIRM TOWARD SYSTEMS-ORIENTED SALES MODEL; FOCUS ON INTERNAL MEDICINE, ENDOCRINOLOGY, CNS
Executive Summary
Lilly's reorganization into disease-based business units announced July 14 is the latest step by the company toward implementing a more systems-oriented sales approach.